Orbimed Advisors - TERNS PHARMACEUTICALS INC ownership

TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 35 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of TERNS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$38,324,249
-42.5%
7,619,1350.0%0.81%
-32.6%
Q2 2023$66,667,431
-26.1%
7,619,1350.0%1.21%
-31.8%
Q1 2023$90,210,558
+16.3%
7,619,1350.0%1.77%
+19.3%
Q4 2022$77,562,794
+76.0%
7,619,135
+1.8%
1.48%
+81.4%
Q3 2022$44,064,000
+368.7%
7,481,204
+97.3%
0.82%
+381.2%
Q2 2022$9,402,000
-16.5%
3,791,2040.0%0.17%
-7.1%
Q1 2022$11,260,000
-58.0%
3,791,2040.0%0.18%
-47.0%
Q4 2021$26,804,000
-32.1%
3,791,2040.0%0.34%
-20.5%
Q3 2021$39,504,000
-15.0%
3,791,2040.0%0.43%
-7.7%
Q2 2021$46,480,000
-44.3%
3,791,2040.0%0.47%
-39.7%
Q1 2021$83,406,0003,791,2040.78%
Other shareholders
TERNS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 6,657,992$33,489,7003.67%
ACUTA CAPITAL PARTNERS, LLC 555,260$2,792,9581.87%
SUVRETTA CAPITAL MANAGEMENT, LLC 6,041,910$30,390,8071.64%
VR Adviser, LLC 3,092,273$15,554,1331.64%
Fairmount Funds Management LLC 2,040,000$10,261,2001.24%
Decheng Capital Management III (Cayman), LLC 714,285$3,592,8541.20%
Deep Track Capital, LP 6,000,000$30,180,0001.16%
Orbimed Advisors 7,619,135$38,324,2490.81%
SILVERARC CAPITAL MANAGEMENT, LLC 500,000$2,515,0000.76%
GREAT POINT PARTNERS LLC 645,899$3,248,8720.59%
View complete list of TERNS PHARMACEUTICALS INC shareholders